Researchers at Banaras Hindu University (BHU) recently discovered population-specific genomic risk markers for oral cancer in eastern Uttar Pradesh. This critical finding addresses the deadliest form of oral cancer in high-burden regions where communities deeply embed smokeless tobacco use. Consequently, this breakthrough could pave the way for earlier diagnoses and personalized screening strategies. Furthermore, global databases do not adequately represent the genetic diversity of North Indian communities. Therefore, developing population-specific tools is absolutely essential.

The Power of Genomic Risk Markers in Oral Cancer Screening

The dual-genomic study integrated mitochondrial DNA profiling and whole-exome sequencing of patients from the Purvanchal region. Specifically, the researchers analyzed samples from ninety-eight individuals in Varanasi, Gorakhpur, and neighboring districts. They discovered that the 16223C polymorphism in the mitochondrial genome was significantly less frequent in cancer patients. Consequently, the absence of this polymorphism increased the risk of developing oral cancer by 8.1 times. Moreover, individuals belonging to Western Eurasian haplogroups showed a much higher susceptibility to the disease. Conversely, those with South Asian haplogroups, particularly M5a, demonstrated a protective trend.

Bridging the Gap in Global Genomic Databases

Furthermore, whole-genome sequencing revealed three novel genes that global cancer databases had never reported before. Combined with six previously known genes, the total number of genes associated with this condition is now nine. Importantly, North Indian populations remain underrepresented in existing global databases. Tobacco consumption in Uttar Pradesh significantly exceeds the national average, making local research highly critical. For this reason, physicians in India must adopt precision medicine strategies that fit their specific patient demographics. Early intervention can drastically improve the five-year survival rate, which currently sits between twenty and forty-five percent.

Frequently Asked Questions

Q1: What are the main genomic risk markers identified in the BHU study?

The study identified the absence of the 16223C polymorphism in the mitochondrial genome as a major risk factor, increasing oral cancer risk by 8.1-fold. Additionally, the researchers identified Western Eurasian haplogroups as higher risk, whereas South Asian haplogroups like M5a showed protective trends.

Q2: Why are population-specific genomic tools necessary for North Indian communities?

Global genomic databases do not adequately represent the genetic architecture of North Indian populations. Since oral cancer in high-burden regions like Purvanchal arises from genetics and tobacco use, tailored genomic tools are crucial.

Q3: Which novel genes were discovered during this research?

The BHU research team identified three previously unreported genes associated with oral cancer. Consequently, the total number of globally identified genes linked to this condition increased from six to nine.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. BHU study finds population-specific genomic markers for oral cancer - ETHealthworld


2. Dubey PK, Mittal N, Chaubey G, Agarwal R, Naveen PG. Population-specific genomic risk markers for oral and maxillofacial malignancies in a high tobacco-exposure cohort from Eastern Uttar Pradesh, India. Bioinformation. 2026;22(3):123-128.